Patents by Inventor Joseph Theodore Lundquist, IV

Joseph Theodore Lundquist, IV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067651
    Abstract: Disclosed are prodrugs of myeloperoxidase (MPO) inhibitors, methods of treating MPO related disorders, e.g., multiple system atrophy, amyotrophic lateral sclerosis, and Huntington's disease, and methods of neuroprotection, which include administering to a patient in need thereof the prodrugs, pharmaceutical compositions including the prodrugs, and kits including the pharmaceutical compositions and instructions for use.
    Type: Application
    Filed: October 9, 2020
    Publication date: February 29, 2024
    Inventors: Gene M. DUBOWCHIK, Joseph Theodore LUNDQUIST, IV, Melody A. MCWHERTER, Jeffrey C. PELLETIER, Allen B. REITZ, Eric STROBEL, Yan ZHANG
  • Publication number: 20110039824
    Abstract: Provided are certain 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate compounds which are useful for modulating the activity of nuclear receptors, such as farnesoid X receptors, and/or for the treatment, prevention, or amelioration diseases or disorders related to the activity of these receptors.
    Type: Application
    Filed: May 13, 2010
    Publication date: February 17, 2011
    Applicant: Wyeth
    Inventors: Joseph Theodore Lundquist, IV, Paige Erin Mahaney, Callain Younghee Kim, Matthew Lantz Crawley
  • Patent number: 7696210
    Abstract: Compounds of Formula I, useful as Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists, are disclosed.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: April 13, 2010
    Assignee: Wyeth
    Inventors: Lloyd Michael Garrick, Daniel Michael Green, Diane Barbara Hauze, Kenneth Lewis Kees, Joseph Theodore Lundquist, IV, Charles William Mann, John Francis Mehlmann, Jeffrey Claude Pelletier, John Francis Rogers, Jr., Jay Edward Wrobel
  • Publication number: 20090137554
    Abstract: Disclosed are chemical entities including compounds of Formula I and pharmaceutically acceptable salts thereof, wherein X is chosen from CN, CF3, CF2H, S(O)nR8, and S(O)2N(R9)R10; Y is chosen from CR11 and N; Z is chosen from O and NH; R3 is chosen from —C(O)R12 and —C(O)N(R9)R10; and n, R1, R2 and R4-R12 are defined herein; compositions comprising one or more such chemical entities; and methods of using one or more such chemical entities for modulating the activity of certain receptors (e.g., farnesoid X) or for the treatment or prevention of one or more symptoms of disease or disorder related to the activity of those receptors.
    Type: Application
    Filed: October 21, 2008
    Publication date: May 28, 2009
    Applicant: Wyeth
    Inventors: John Francis Mehlmann, Joseph Theodore Lundquist, IV, Paige Erin Mahaney, Matthew Lantz Crawley, Callain Younghee Kim
  • Publication number: 20090131409
    Abstract: Disclosed are chemical entities including compounds of Formula I and pharmaceutically acceptable salts thereof, wherein X is chosen from CN, CF3, CF2H, S(O)nR6, and S(O)2N(R9)R10; Y is chosen from CR11 and N; Z is chosen from O and NH; R3 is chosen from —C(O)R12 and —C(O)N(R9)R10; and n, R1, R2 and R4-R12 are defined herein; compositions comprising one or more such chemical entities; and methods of using one or more such chemical entities for modulating the activity of certain receptors (e.g., farnesoid X) or for the treatment or prevention of one or more symptoms of disease or disorder related to the activity of those receptors.
    Type: Application
    Filed: October 21, 2008
    Publication date: May 21, 2009
    Applicant: Wyeth
    Inventors: John Francis Mehlmann, Joseph Theodore Lundquist, IV, Paige Erin Mahaney, Matthew Lantz Crawley, Callain Younghee Kim
  • Publication number: 20090069319
    Abstract: The present invention relates to imidazopyridine analogs, methods of making imidazopyridine analogs, compositions comprising an imidazopyridine analog, and methods for treating canonical Wnt-?-catenin cellular messaging system-related disorders comprising administering to a subject in need thereof an effective amount of an imidazopyridine analog.
    Type: Application
    Filed: August 26, 2008
    Publication date: March 12, 2009
    Applicant: Wyeth
    Inventors: Joseph Theodore Lundquist, IV, Stephen Marc Bowen, John Francis Mehlmann, Jeffrey Claude Pelletier, Matthew Douglas Vera
  • Publication number: 20090054392
    Abstract: The present invention relates to naphthylpyrimidine analogs, methods of making naphthylpyrimidine analogs, compositions comprising a naphthylpyrimidine analog, and methods for treating canonical Wnt-?-catenin cellular messaging system-related disorders comprising administering to a subject in need thereof an effective amount of a naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analog.
    Type: Application
    Filed: August 19, 2008
    Publication date: February 26, 2009
    Applicant: Wyeth
    Inventors: Jeffrey Claude Pelletier, Luciana de Araujo Felix, Daniel Michael Green, Diane Barbara Hauze, Joseph Theodore Lundquist, IV, Charles William Mann, John Francis Mehlmann, John Francis Rogers, JR., Matthew Douglas Vera, Albert John Molinari